skip to main content
Show Results with:

Kv1.3 inhibition as a potential microglia-targeted therapy for Alzheimer’s disease: preclinical proof of concept

Maezawa, I. et al.

BRAIN VOL 141; NUMBER 2, ; 2018, 596-612 -- Oxford University Press

Check library holdings

Searching Remote Databases, Please Wait